Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HINES

Showing results (421-430 of 424) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 424 results.
The Lancet. Microbe|October 19, 2024
Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trialAbinash Virk, Angel P Strasburg, Kami D Kies, et al.
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
Plos Biology|January 7, 2015
Finding our way through phenotypesAndrew R Deans, Suzanna E Lewis, Eva Huala, et al.
Pageof 43

Showing results (421-430 of 424) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 424 results.
The Lancet. Microbe|October 19, 2024
Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trialAbinash Virk, Angel P Strasburg, Kami D Kies, et al.
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
Plos Biology|January 7, 2015
Finding our way through phenotypesAndrew R Deans, Suzanna E Lewis, Eva Huala, et al.
Pageof 43